Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation study

被引:83
作者
Morden, James P. [1 ,2 ]
Lambert, Paul C. [2 ]
Latimer, Nicholas [3 ]
Abrams, Keith R. [2 ]
Wailoo, Allan J. [3 ]
机构
[1] ICR CTSU, Inst Canc Res, Sutton SM2 5NG, Surrey, England
[2] Univ Leicester, Dept Hlth Sci, Ctr Biostat & Genet Epidemiol, Leicester LE1 7RH, Leics, England
[3] Univ Sheffield, ScHARR, Sheffield S1 4DA, S Yorkshire, England
基金
英国工程与自然科学研究理事会;
关键词
CLINICAL-TRIALS; SURVIVAL ANALYSIS; CONCORDE TRIAL; MODELS; NONCOMPLIANCE; INTERVENTIONS; INTENTION; INFERENCE; EXAMPLE;
D O I
10.1186/1471-2288-11-4
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: We investigate methods used to analyse the results of clinical trials with survival outcomes in which some patients switch from their allocated treatment to another trial treatment. These included simple methods which are commonly used in medical literature and may be subject to selection bias if patients switching are not typical of the population as a whole. Methods which attempt to adjust the estimated treatment effect, either through adjustment to the hazard ratio or via accelerated failure time models, were also considered. A simulation study was conducted to assess the performance of each method in a number of different scenarios. Results: 16 different scenarios were identified which differed by the proportion of patients switching, underlying prognosis of switchers and the size of true treatment effect. 1000 datasets were simulated for each of these and all methods applied. Selection bias was observed in simple methods when the difference in survival between switchers and non-switchers were large. A number of methods, particularly the AFT method of Branson and Whitehead were found to give less biased estimates of the true treatment effect in these situations. Conclusions: Simple methods are often not appropriate to deal with treatment switching. Alternative approaches such as the Branson & Whitehead method to adjust for switching should be considered.
引用
收藏
页数:20
相关论文
共 47 条
[1]  
ABRAMS K, 2008, BEVACIZUMAB SORAFENI
[2]  
[Anonymous], 2003, Modelling Survival Data in Medical Research
[3]   Generating survival times to simulate Cox proportional hazards models [J].
Bender, R ;
Augustin, T ;
Blettner, M .
STATISTICS IN MEDICINE, 2005, 24 (11) :1713-1723
[4]   Survival Analysis Part II: Multivariate data analysis - an introduction to concepts and methods [J].
Bradburn, MJ ;
Clark, TG ;
Love, SB ;
Altman, DG .
BRITISH JOURNAL OF CANCER, 2003, 89 (03) :431-436
[5]   Estimating a treatment effect in survival studies in which patients switch treatment [J].
Branson, M ;
Whitehead, J .
STATISTICS IN MEDICINE, 2002, 21 (17) :2449-2463
[6]   The design of simulation studies in medical statistics [J].
Burton, Andrea ;
Altman, Douglas G. ;
Royston, Patrick ;
Holder, Roger L. .
STATISTICS IN MEDICINE, 2006, 25 (24) :4279-4292
[7]  
Coleman M., 1999, CANC SURVIVAL TRENDS
[8]  
Efron B, 1993, INTRO BOOTSTRAP MONO
[9]   Post-randomisation exclusions:: the intention to treat principle and excluding patients from analysis [J].
Fergusson, D ;
Aaron, SD ;
Guyatt, G ;
Hébert, P .
BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7365) :652-654
[10]   Principal stratification in causal inference [J].
Frangakis, CE ;
Rubin, DB .
BIOMETRICS, 2002, 58 (01) :21-29